Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma

by Mehta, Akash M., Jordanova, Ekaterina S., Kenter, Gemma G., Ferrone, Soldano, Fleuren, Gert- Jan
Published 2007

Cervical cancer survivors’ and partners’ experiences with sexual dysfunction and psychosexual support

by Vermeer, Willemijn M., Bakker, Rinske M., Kenter, Gemma G., Stiggelbout, Anne M., ter Kuile, Moniek M.
Published 2015

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer

by Kloth, Judith N, Oosting, Jan, van Wezel, Tom, Szuhai, Karoly, Knijnenburg, Jeroen, Gorter, Arko, Kenter, Gemma G, Fleuren, Gert Jan, Jordanova, Ekaterina S
Published 2007

A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass

by Wegdam, Wouter, Moerland, Perry D, Meijer, Danielle, de Jong, Shreyas M, Hoefsloot, Huub C J, Kenter, Gemma G, Buist, Marrije R, Aerts, Johannes MF G
Published 2012

Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases

by Ferns, Debbie M., Heeren, A. Marijne, Samuels, Sanne, Bleeker, Maaike C. G., de Gruijl, Tanja D., Kenter, Gemma G., Jordanova, Ekaterina S.
Published 2016

Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer

by Rutten, Marianne J., Sonke, Gabe S., Westermann, Anneke M., van Driel, Willemien J., Trum, Johannes W., Kenter, Gemma G., Buist, Marrije R.
Published 2015

Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area

by Heeren, A. Marijne, de Boer, Eline, Bleeker, Maaike C.G., Musters, René J.P., Buist, Marrije R., Kenter, Gemma G., de Gruijl, Tanja D., Jordanova, Ekaterina S.
Published 2015

Label-Free LC-MSe in Tissue and Serum Reveals Protein Networks Underlying Differences between Benign and Malignant Serous Ovarian Tumors

by Wegdam, Wouter, Argmann, Carmen A., Kramer, Gertjan, Vissers, Johannes P., Buist, Marrije R., Kenter, Gemma G., Aerts, Johannes M. F. G., Meijer, Danielle, Moerland, Perry D.
Published 2014

Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix

by Heeren, A Marijne, Punt, Simone, Bleeker, Maaike CG, Gaarenstroom, Katja N, van der Velden, Jacobus, Kenter, Gemma G, de Gruijl, Tanja D, Jordanova, Ekaterina S
Published 2016

Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study

by Samuels, Sanne, Balint, Balazs, von der Leyen, Heiko, Hupé, Philippe, de Koning, Leanne, Kamoun, Choumouss, Luscap-Rondof, Windy, Wittkop, Ulrike, Bagrintseva, Ksenia, Popovic, Marina, Kereszt, Atttila, Berns, Els, Kenter, Gemma G, Jordanova, Ekaterina S, Kamal, Maud, Scholl, Susy
Published 2016

Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study

by Rutten, Marianne J, Gaarenstroom, Katja N, Van Gorp, Toon, van Meurs, Hannah S, Arts, Henriette JG, Bossuyt, Patrick M, Ter Brugge, Henk G, Hermans, Ralph HM, Opmeer, Brent C, Pijnenborg, Johanna MA, Schreuder, Henk WR, Schutter, Eltjo MJ, Spijkerboer, Anje M, Wensveen, Celesta WM, Zusterzeel, Petra, Mol, Ben Willem J, Kenter, Gemma G, Buist, Marrije R
Published 2012

A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions

by de Vos van Steenwijk, Peggy J., Ramwadhdoebe, Tamara H., Löwik, Margriet J. G., van der Minne, Caroline E., Berends-van der Meer, Dorien M. A., Fathers, Lorraine M., Valentijn, A. Rob P. M., Oostendorp, Jaap, Fleuren, Gert Jan, Hellebrekers, Bart W. J., Welters, Marij J. P., van Poelgeest, Mariette I., Melief, Cornelis J. M., Kenter, Gemma G., van der Burg, Sjoerd H.
Published 2012

TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients

by Kvistborg, Pia, Shu, Chengyi Jenny, Heemskerk, Bianca, Fankhauser, Manuel, Thrue, Charlotte Albæk, Toebes, Mireille, van Rooij, Nienke, Linnemann, Carsten, van Buuren, Marit M., Urbanus, Jos H.M., Beltman, Joost B., thor Straten, Per, Li, Yong F., Robbins, Paul F., Besser, Michal J., Schachter, Jacob, Kenter, Gemma G., Dudley, Mark E., Rosenberg, Steven A., Haanen, John B.A.G., Hadrup, Sine Reker, Schumacher, Ton N.M.
Published 2012

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

by van Poelgeest, Mariette I E, Welters, Marij J P, van Esch, Edith M G, Stynenbosch, Linda F M, Kerpershoek, Gijs, van Persijn van Meerten, Els L, van den Hende, Muriel, Löwik, Margriet J G, Berends-van der Meer, Dorien M A, Fathers, Lorraine M, Valentijn, A Rob P M, Oostendorp, Jaap, Fleuren, Gert Jan, Melief, Cornelis J M, Kenter, Gemma G, van der Burg, Sjoerd H
Published 2013